Aurora Cannabis (ACB) ended 2018 on a tough note, primarily because of the broader market correction and its timing in connection to Aurora being listed on the NYSE.

That took the steam out of its strong momentum, and its share price rapidly declined.

Looking at what’s ahead for Aurora Cannabis for 2019, I think it’s going to be a tremendous year for the company, as it confirms its production capacity and accompanying revenue are the real deal.

We’ll look specifically at Aurora’s dominating production and revenue growth in 2019, what the market is looking for, and what type of investors should take a position in the cannabis producer for the long haul.

While that’s what we will primarily look at in this article, it’s also important to note that I see Aurora as a long-term holding now. Those willing to go through the inevitable volatility that comes with an emerging industry, will be rewarded strongly in the years ahead.

Production and sales growth in 2019

In its last earnings report Aurora reported it would boost production in November to 70,000 kilograms annually, and by the end of 2018 that would increase to 100,000 kilograms annually. By the end of June 2019, guidance is it’ll add more than 50 percent to the 2018 total, bringing it to over 150,000 kilograms in annual production by that time.

On the sales side, Wall Street projects it’ll grow at just under 600 percent in 2019 for Aurora; that’s by far the largest sales growth rate among its major competitors.

Source: 420 Intel
View Original Post

Leave a Comment


Start typing and press Enter to search

Do You Support Medical Cannabis?

Show your support. Join millions of marijuana supporters here!

Welcome to the CCC Family!